World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
56
Citations
12107
World Ranking
3711
National Ranking
1711

Edus H. Warren publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Edus H. Warren sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 230 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Edus H. Warren D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Edus H. Warren sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 56 D-Index — 26th percentile

26% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Edus H. Warren is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research primarily focuses on the field of Medicine, with significant contributions to Oncology, Pathology and Forensic Medicine, Immunology, Genetics, and Molecular Biology.

The scientist's main topics of research include:

  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Chronic Lymphocytic Leukemia Research
  • Cancer Immunotherapy and Biomarkers
  • Cancer Genomics and Diagnostics
  • Immunotherapy and Immune Responses
  • Cutaneous lymphoproliferative disorders research

Edus H. Warren has frequently collaborated with the following co-authors:

  • Ajay K. Gopal
  • Ryan C. Lynch
  • Chaitra S. Ujjani
  • Mazyar Shadman
  • Brian G. Till

Key publication venues for their work include:

  • Blood
  • Blood Advances
  • Transplantation and Cellular Therapy
  • Hematological Oncology
  • British Journal of Haematology

The following are recent publications by Edus H. Warren:

  • Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study (2021, The Lancet Haematology)
  • Precision Medicine in Low- and Middle-Income Countries (2022, Annual Review of Pathology Mechanisms of Disease)
  • Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma (2023, Blood)
  • Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma (2023, Nature Communications)
  • RNA helicase, DDX3X, is actively recruited to sites of DNA damage in live cells (2021, DNA Repair)

Best Publications

  • Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells

    Harlan S. Robins;Paulo V. Campregher;Santosh K. Srivastava;Abigail Wacher

  • Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria

    Mary E D Flowers;Yoshihiro Inamoto;Paul A. Carpenter;Stephanie J. Lee

  • Overlap and Effective Size of the Human CD8+ T Cell Receptor Repertoire

    Harlan S. Robins;Santosh K. Srivastava;Paulo V. Campregher;Cameron J. Turtle

  • Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK–modified donor T cells after allogeneic hematopoietic cell transplantation

    Carolina Berger;Carolina Berger;Mary E. Flowers;Mary E. Flowers;Edus H. Warren;Edus H. Warren;Stanley R. Riddell;Stanley R. Riddell

  • Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.

    H. Joachim Deeg;Barry Storer;John T. Slattery;Claudio Anasetti

  • Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.

    Sophia S B Randolph;Theodore A Gooley;Edus H Warren;Frederick R Appelbaum

  • Toward eliminating HLA class I expression to generate universal cells from allogeneic donors

    Hiroki Torikai;Andreas Reik;Frank Soldner;Edus H. Warren

  • Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution.

    Edus H. Warren;Philip D. Greenberg;Stanley R. Riddell

  • CD8+ minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells

    Dominique Bonnet;Edus H. Warren;Philip D. Greenberg;John E. Dick

  • A human minor histocompatibility antigen resulting from differential expression due to a gene deletion

    Makoto Murata;Edus H. Warren;Edus H. Warren;Stanley R. Riddell;Stanley R. Riddell

  • Evaluation of NIH consensus criteria for classification of late acute and chronic GVHD

    Afonso C. Vigorito;Paulo V. Campregher;Barry E. Storer;Paul A. Carpenter

  • An antigen produced by splicing of noncontiguous peptides in the reverse order

    Edus H. Warren;Edus H. Warren;Nathalie J. Vigneron;Nathalie J. Vigneron;Marc A. Gavin;Marc A. Gavin;Pierre G. Coulie

  • The Human UTY Gene Encodes a Novel HLA-B8-Restricted H-Y Antigen

    Edus H. Warren;Marc A. Gavin;Elizabeth Simpson;Phillip Chandler

  • The Immunogenicity of a New Human Minor Histocompatibility Antigen Results from Differential Antigen Processing

    Anthony G. Brickner;Edus H. Warren;Edus H. Warren;Jennifer A. Caldwell;Yoshiki Akatsuka;Yoshiki Akatsuka

  • Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens

    Edus H. Warren;Edus H. Warren;Nobuharu Fujii;Yoshiki Akatsuka;Colette N. Chaney

  • Dynamics of the Cytotoxic T Cell Response to a Model of Acute Viral Infection

    William S. DeWitt;Ryan O. Emerson;Paul Lindau;Marissa Vignali

  • Non-Myeloablative Transplants for Malignant Disease

    Rainer F. Storb;Richard Champlin;Stanley R. Riddell;Makato Murata

  • Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamide

    Christopher G. Kanakry;David G. Coffey;Andrea M.H. Towlerton;Ante Vulic

  • Effects of contralateral sound on auditory-nerve responses. II. Dependence on stimulus variables.

    Edus H Warren;Edus H Warren;M.Charles Liberman;M.Charles Liberman

  • The PANE1 gene encodes a novel human minor histocompatibility antigen that is selectively expressed in B-lymphoid cells and B-CLL.

    Anthony G. Brickner;Anne M. Evans;Jeffrey K. Mito;Suzanne M. Xuereb

Frequent Co-Authors

Stanley R. Riddell
Stanley R. Riddell University of Washington
Paul J. Martin
Paul J. Martin Fred Hutchinson Cancer Research Center
Barry E. Storer
Barry E. Storer Fred Hutchinson Cancer Research Center
John A. Hansen
John A. Hansen Fred Hutchinson Cancer Research Center
Cameron J. Turtle
Cameron J. Turtle Fred Hutchinson Cancer Research Center
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Ted Gooley
Ted Gooley Fred Hutchinson Cancer Research Center
Stephanie J. Lee
Stephanie J. Lee Fred Hutchinson Cancer Research Center
Harlan Robins
Harlan Robins Adaptive Biotechnologies (United States)
Mary E.D. Flowers
Mary E.D. Flowers Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related online degrees can open up various career pathways in healthcare and research. Many students begin with foundational programs such as online RN programs for non nurses in Florida, which provide a comprehensive entry into the nursing field, even without prior medical experience.

Accelerated programs offer a faster route, especially for students looking to transition or advance their careers. The accelerated FNP programs are designed to efficiently prepare family nurse practitioners to meet growing healthcare demands.

For nurses aiming to specialize in critical and acute care settings, understanding how to move from an FNP role is essential. Resources like the fnp to acute care np pathway provide valuable guidance on this transition.

Additionally, some students may seek programs that are more accessible and easier to enter. Exploring the easiest accelerated nursing programs can be a practical step toward gaining qualifications quickly while maintaining quality education standards.

Best Scientists Citing Edus H. Warren

Trending Scientists

Recently Published Articles